General Information of This Drug (ID: DMQW6B6)

Drug Name
Seviprotimut-L   DMQW6B6

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Melanoma DIS1RRCY 2C30 Phase 3 [1]
Merkel cell carcinoma DISDJJ4U 2C34 Phase 3 [1]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)